Anders Boyd
Anders completed his Master’s degree in Public Health at the University of Minnesota. He continued his doctoral studies at Université Pierre et Marie Curie, which gave way to a PhD thesis considering the various ways to model viral replication and liver fibrosis in HIV-positive individuals with multiple viral hepatitis infections.
He was awarded a post-doctoral fellowship from the French Agency for Research on AIDS and Viral Hepatitis to study the evolution of hepatitis B virus genetic variability in two cohorts of HIV-HBV co-infected individuals in France and Côte d’Ivoire. He then received a second post-doctoral fellowship from Sidaction to further explore the virological, serological, and clinical implications of HIV-HBV co-infection in these two cohorts. He has also worked as a methodologist for a number of projects on topics such as large-scale testing for viral infections, cardiovascular disease, metabolism, antimicrobial resistance, and mental health.
Anders’ research now focuses on methodological approaches to examining trends in co-morbidities and understanding their determinants in HIV-positive individuals. In addition to his work at SHM, Anders also works at the GGD Amsterdam, where he contributes to several projects on sexually transmitted disease and HIV prevention.
Key publications
Higher Mortality Despite Early Antiretroviral Therapy in Human Immunodeficiency Virus and Hepatitis B Virus (HBV)-Coinfected Patients With High HBV Replication
Kouamé GM, Boyd A, Moh R, Badje A, Gabillard D, Ouattara E, Ntakpe JB, Emième A, Maylin S, Chekaraou MA, Eholié SP, Zoulim F, Lacombe K, Anglaret X, Danel C; French National Agency for Research on AIDS and Viral Hepatitis (ANRS) 12136 Temprano and ANRS 12240 VarBVA Study Groups.
Clin Infect Dis. 2018 Jan 6;66(1):112-120. doi: 10.1093/cid/cix747.
Platelet reactivity in human immunodeficiency virus infected patients on dual antiplatelet therapy for an acute coronary syndrome: the EVERE2ST-HIV study
Hauguel-Moreau M, Boccara F, Boyd A, Salem JE, Brugier D, Curjol A, Hulot JS, Kerneis M, Galier S, Cohen A, Montalescot G, Collet JP, Silvain J.
Eur Heart J. 2017 Jun 1;38(21):1676-1686
Decay of ccc-DNA marks persistence of intrahepatic viral DNA synthesis under tenofovir in HIV-HBV co-infected patients
Boyd A, Lacombe K, Lavocat F, Maylin S, Miailhes P, Lascoux-Combe C, Delaugerre C, Girard PM, Zoulim F.
J Hepatol. 2016 Oct;65(4):683-691. doi: 10.1016/j.jhep.2016.05.014. Epub 2016 May 19.
Rates and determinants of hepatitis B 'e' antigen and hepatitis B surface antigen seroclearance during long-term follow-up of patients coinfected with HIV and hepatitis B virus
Boyd A, Gozlan J, Miailhes P, Lascoux-Combe C, Cam MS, Rougier H, Zoulim F, Girard PM, Lacombe K.
AIDS. 2015 Sep 24;29(15):1963-73.
Persistent viremia in human immunodeficiency virus/hepatitis B coinfected patients undergoing long-term tenofovir: virological and clinical implications
Boyd A, Gozlan J, Maylin S, Delaugerre C, Peytavin G, Girard PM, Zoulim F, Lacombe K.
Hepatology. 2014 Aug;60(2):497-507. doi: 10.1002/hep.27182. Epub 2014 Jun 20.
High incidence of treatment-induced and vaccine-escape hepatitis B virus mutants among human immunodeficiency virus/hepatitis B-infected patients
Lacombe K, Boyd A, Lavocat F, Pichoud C, Gozlan J, Miailhes P, Lascoux-Combe C, Vernet G, Girard PM, Zoulim F.
Hepatology. 2013 Sep;58(3):912-22. doi: 10.1002/hep.26374. Epub 2013 Jun 25.